TP53 and cancer: In this study, we found that GS-002 significantly induced ATF-3 expression and apoptosis in p53-null Hep3B cells, indicating that GS-002 induced ATF-3 in a p53-independent manner, and GS-002 was able to induce apoptosis in those cancer cells even with mutant p53.